1672-7738
2015 Issue 12
..............page:681-681
A research and development overview of Fingolimod
NIU Jun-xing;,HU Li-hong;
NIU Jun-xing;,HU Li-hong;
..............page:683-687,698
Study on the risk assessment of drug hepatoxicty by high content analysis
GAO Yang;,HU Yu-chi;,ZUO Ze-ping;,WANG Zhi-bin;,JIN Jia-jin;,WANG Li-na;,CHENG Yuan;
GAO Yang;,HU Yu-chi;,ZUO Ze-ping;,WANG Zhi-bin;,JIN Jia-jin;,WANG Li-na;,CHENG Yuan;
..............page:688-691,702
Comparative study on the model of intracerebral hemorrhage of collagenase and autologous blood establishment
CHEN Wei;,HUANG Shu-wu;,GAO Yu-guang;,HE Qing;,HE Qian-chao;,HUANG De-qing;,ZHANG Yuan-kan;,LIU Tai;
CHEN Wei;,HUANG Shu-wu;,GAO Yu-guang;,HE Qing;,HE Qian-chao;,HUANG De-qing;,ZHANG Yuan-kan;,LIU Tai;
..............page:692-695
Study on release rate in vitro of emodion in colon targeting Huchangqingdu Pellets
MA Chuan-jiang;,SUN Ping;,LIU Le-yang;
MA Chuan-jiang;,SUN Ping;,LIU Le-yang;
..............page:696-698
The effect of corilagin for IAPP,GLP -1 and INS of rats which fed by fructose
ZHANG Jian-bo;,CHEN Ping;,XIE Yu;,GONG Jian-yu;,FAN Yuan;
ZHANG Jian-bo;,CHEN Ping;,XIE Yu;,GONG Jian-yu;,FAN Yuan;
..............page:699-702
Determination of phillyrin in Rutong′an Oral Solution by HPLC
TAI Xiao-peng;,ZANG Heng-chang;
TAI Xiao-peng;,ZANG Heng-chang;
..............page:703-705
Determination of the impurity C in phenylephrine hydrochloride by main constituent own control method with correction factor
XU Liang-liang;,ZHU Xiao-lin;,SU Li;
XU Liang-liang;,ZHU Xiao-lin;,SU Li;
..............page:706-708,718
The method of microbial limit examination and verification of Ray Furnace Lotion
LI Xiu-zhen;,SONG Xiu-rong;,LIU Feng-qin;,LI Wen;
LI Xiu-zhen;,SONG Xiu-rong;,LIU Feng-qin;,LI Wen;
..............page:709-710,713
Comparison of antimicrobial potency of Ceftriaxone Sodium Injection from different manufactures by cup - plate method
GUO Xin-ying;,ZANG Heng-chang;,WANG Yan-hou;
GUO Xin-ying;,ZANG Heng-chang;,WANG Yan-hou;
..............page:711-713
The prescription process and quality standard of Yangyin Shengji Membrane
LUO Hui-sheng;,KOU Heng-lie;,FAN Jing;,WANG Xun;
LUO Hui-sheng;,KOU Heng-lie;,FAN Jing;,WANG Xun;
..............page:714-718
Preparation and quality control of Fluconazole Ophthalmic Gel
MAN Yu-qing;,WEI Chuan-mei;,LIU Ming-hua;,ZUO Xiao-xin;,HU Li-min;
MAN Yu-qing;,WEI Chuan-mei;,LIU Ming-hua;,ZUO Xiao-xin;,HU Li-min;
..............page:719-721,730
Research progress on the treatment after resistance to first generation EGFR - TKI in patients with non - small cell lung cancer
DENG Wu-sheng;,SUN Jie;
DENG Wu-sheng;,SUN Jie;
..............page:722-725,740
Research progress of the effect and mechanism of oxidative stress on vasoactive substances
YANG Wen-juan;,HONG Ze;,YAN Si-min;,DING Qi-long;
YANG Wen-juan;,HONG Ze;,YAN Si-min;,DING Qi-long;
..............page:726-730
Drug transporter of liver and its clinical significance research progress
FU Chao;,LIU Yang;
FU Chao;,LIU Yang;
..............page:731-733,743
Clinical study of Thalidomide combined with CIK cells on the treatment of lymphoma
LI Jing;,MENG Di;,YANG Lu;,YANG Shu;
LI Jing;,MENG Di;,YANG Lu;,YANG Shu;
..............page:734-736
..............page:736-736
Analysis of the drug wastage in PIVAS
ZHAO Fang-yun;,CAI Wen-cai;
ZHAO Fang-yun;,CAI Wen-cai;
..............page:737-740
Improved synthesis of 5 - allyloxy -2,3,4 - tris(benzyloxy)pentan -1 - ol
XI Zun-bo;,LI Xin;,MA Shu-tao;
XI Zun-bo;,LI Xin;,MA Shu-tao;
..............page:741-743
can zuo pu tao tang zhu she ye zhi gao xue ya wei xiang 1 li
zhang xia lan ;
zhang xia lan ;
..............page:744-744